These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24842435)

  • 21. Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.
    Zhu WG; Xiong QM; Hong K
    Tex Heart Inst J; 2015 Feb; 42(1):6-15. PubMed ID: 25873792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation.
    Golive A; May HT; Bair TL; Jacobs V; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
    Am J Cardiol; 2017 Jul; 120(1):75-82. PubMed ID: 28483209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effectiveness and safety of oral anticoagulation treatment with acenocoumarol in non-valvular atrial fibrillation].
    Castro C; Bustos L; Ocampo R; Molina E; Cabrero P; Vergara R; Lanas F
    Rev Med Chil; 2017 Oct; 145(10):1243-1251. PubMed ID: 29488564
    [No Abstract]   [Full Text] [Related]  

  • 24. CHA
    Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
    Steinberg BA; Shrader P; Kim S; Thomas L; Fonarow GC; Ansell J; Kowey PR; Singer DE; Gersh BJ; Mahaffey KW; Peterson ED; Piccini JP;
    Am Heart J; 2016 Nov; 181():145-152. PubMed ID: 27823686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of insertable cardiac monitors in anticoagulation therapy in patients with atrial fibrillation at high risk of bleeding.
    Mascarenhas DA; Farooq MU; Ziegler PD; Kantharia BK
    Europace; 2016 Jun; 18(6):799-806. PubMed ID: 26614520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Lip GY; Chen SA
    Heart Rhythm; 2014 Oct; 11(10):1752-9. PubMed ID: 24952148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stroke risk in atrial fibrillation: Do we anticoagulate CHADS2 or CHA2DS2-VASc ≥1, or higher?
    Olesen JB; Torp-Pedersen C
    Thromb Haemost; 2015 Jun; 113(6):1165-9. PubMed ID: 25743201
    [No Abstract]   [Full Text] [Related]  

  • 29. ACP Journal Club. Review: In AF or VTE, direct oral anticoagulants reduce fatal bleeding compared with vitamin K antagonists.
    Lazo-Langner A
    Ann Intern Med; 2015 Oct; 163(8):JC2. PubMed ID: 26502139
    [No Abstract]   [Full Text] [Related]  

  • 30. Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality.
    Rivera-Caravaca JM; Marín F; Esteve-Pastor MA; Valdés M; Vicente V; Roldán V; Lip GYH
    Int J Clin Pract; 2018 Mar; 72(3):e13069. PubMed ID: 29436121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation.
    Marcucci M; Nobili A; Tettamanti M; Iorio A; Pasina L; Djade CD; Franchi C; Marengoni A; Salerno F; Corrao S; Violi F; Mannucci PM;
    Eur J Intern Med; 2013 Dec; 24(8):800-6. PubMed ID: 24035703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cardioembolic stroke in atrial fibrillation and new anticoagulation criteria: a therapeutic dare].
    Perez-Ortega I; Moniche-Alvarez F; Jimenez-Hernandez MD; Gonzalez-Marcos JR
    Rev Neurol; 2012 Jul; 55(2):74-80. PubMed ID: 22760766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS
    Chapman SA; St Hill CA; Little MM; Swanoski MT; Scheiner SR; Ware KB; Lutfiyya MN
    BMC Health Serv Res; 2017 Feb; 17(1):127. PubMed ID: 28187730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
    Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
    Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACP Journal Club. In atrial fibrillation, the ATRIA risk score better predicted stroke than CHADS2 and CHA2DS2-VASc scores.
    Calenda BW; Granger CB
    Ann Intern Med; 2016 Feb; 164(4):JC23. PubMed ID: 26882308
    [No Abstract]   [Full Text] [Related]  

  • 37. Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants.
    Guo Y; Lip GY; Apostolakis S
    Hosp Pract (1995); 2013 Feb; 41(1):71-8. PubMed ID: 23466969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in The Netherlands.
    Jacobs MS; van Leent MWJ; Tieleman RG; Jansman FGA; Cao Q; Postma MJ; van Hulst M
    J Med Econ; 2017 Dec; 20(12):1231-1236. PubMed ID: 28766370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stroke and bleeding risk evaluation in atrial fibrillation: results of the European heart rhythm association survey.
    Larsen TB; Potpara T; Dagres N; Pison L; Estner H; Blomström-Lundqvist C;
    Europace; 2014 May; 16(5):698-702. PubMed ID: 24798958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
    Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.